Stefan K.F. Schwabe

2016

In 2016, Stefan K.F. Schwabe earned a total compensation of $1.2M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$159,000
Option Awards$649,000
Salary$366,583
Other$41,082
Total$1,215,665

Schwabe received $649K in option awards, accounting for 53% of the total pay in 2016.

Schwabe also received $159K in non-equity incentive plan, $366.6K in salary and $41.1K in other compensation.

Rankings

In 2016, Stefan K.F. Schwabe's compensation ranked 7,314th out of 14,075 executives tracked by ExecPay. In other words, Schwabe earned more than 48.0% of executives.

ClassificationRankingPercentile
All
7,314
out of 14,075
48th
Division
Manufacturing
2,759
out of 5,489
50th
Major group
Chemicals And Allied Products
902
out of 1,895
52nd
Industry group
Drugs
701
out of 1,538
54th
Industry
Pharmaceutical Preparations
558
out of 1,176
53rd
Source: SEC filing on April 27, 2017.

Schwabe's colleagues

We found four more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2016.

2016

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2016

Victor Vaughn

Supernus Pharmaceuticals

Senior Vice President of Sales and Marketing

2016

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2016

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like